Blog
RSS FeedPosted by Michael Wonder on 10 Dec 2024
December 2024 decisions
9 December 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 12 Nov 2024
November 2024 decisions
11 November 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 08 Oct 2024
October 2024 decisions
7 October 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 09 Sep 2024
SMC - September 2024 decisions
9 September 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 13 Aug 2024
SMC - August 2024 decisions
12 August 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 16 Jul 2024
SMC - July 2024 decisions
8 July 2024 - Voretigene neparvovec (Luxturna) was accepted for the treatment of adults and children with an extremely rare inherited ...
Posted by Michael Wonder on 10 Jun 2024
SMC - June 2024 decisions
10 June 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 14 May 2024
SMC - May 2024 decisions
13 May 2024 - The SMC has today published advice on two medicines. ...
Posted by Michael Wonder on 12 Mar 2024
SMC - March 2024 decisions
11 March 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 13 Feb 2024
SMC - February 2024 decisions
12 February 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 15 Jan 2024
SMC - January 2024 decisions
15 January 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 11 Dec 2023
SMC - December 2023 decisions
11 December 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 13 Nov 2023
SMC - November 2023 decisions
13 November 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 10 Oct 2023
Lynparza (olaparib) accepted for use in Scotland as adjuvant treatment for patients with germline BRCA mutated HER2 negative high risk early breast cancer
9 October 2023 - First and only approved medicine in Scotland which targets germline (hereditary) BRCA mutations in early breast cancer ...
Posted by Michael Wonder on 10 Oct 2023
AbbVie’s Aquipta (atogepant) is now available in Scotland for the prevention of migraines in adults
9 October 2023 - The SMC has accepted Aquipta (atogepant), the oral, once daily calcitonin gene-related peptide receptor antagonist for restricted ...